Bruker (BRKR) SEC Filings: History & Chart

Bruker Corporation(BRKR)

Medical - Devices · Billerica, MA

$60.16-3.70 (-5.80%)

Delayed quote: Oct 6, 2026, 10:25 AM EDT

About Bruker Corporation

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.

Billerica, MA

11,085 employees

www.bruker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Frank H. Laukien

View full financials

Form	Filing Date	Accepted	Document
4	Sep 16, 2026	Sep 16, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
8-K	Aug 14, 2026	Aug 14, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 11, 2026	Aug 11, 2026	View filing
4	Aug 11, 2026	Aug 11, 2026	View filing
4	Aug 11, 2026	Aug 11, 2026	View filing
SC 13G/A	Aug 6, 2026	Aug 6, 2026	View filing
10-Q	Aug 5, 2026	Aug 5, 2026	View filing
8-K	Aug 4, 2026	Aug 4, 2026	View filing
8-K	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
3	Jul 10, 2026	Jul 10, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
S-3ASR	Jun 12, 2026	Jun 12, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
8-K/A	May 29, 2026	May 29, 2026	View filing
8-K	May 21, 2026	May 21, 2026	View filing
4	May 19, 2026	May 19, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
8-K	May 15, 2026	May 15, 2026	View filing
SC 13G/A	May 15, 2026	May 15, 2026	View filing

SEC Filings

Recent Filings